Current Issue February 2012, Vol. 129, No. 2

Issue Highlights

Use of anticoagulants in elderly patients
February 2012(Vol. 129 | No. 2 | Pages 107-115)
Rupert M. Bauersachs

Platelet dysfunction in vascular pathologies and how can it be treated
February 2012(Vol. 129 | No. 2 | Pages 116-126)
Nicoleta Alexandru, Doina Popov, Adriana Georgescu

Risk assessment models for thromboprophylaxis of medical patients
February 2012(Vol. 129 | No. 2 | Pages 127-132)
Meyer M. Samama, Sophie Combe, Jacqueline Conard, Marie-Helene Horellou
- Full Text
- PDF (159 KB)

Foreword
27 January 2012
Giovanni de Gaetano, Chiara Cerletti
- PDF (87 KB)
The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets
27 January 2012
Martina Nylander, Abdimajid Osman, Sofia Ramström, Emma Åklint, Anders Larsson, Tomas L. Lindahl
Abstract: Introduction: Arterial thrombi contain more platelets than venous thrombi and are more resistant to fibrinolysis. This resistance could partly be due to plasminogen activator inhibitor 1 (PA...
Effect of the Factor Xa Inhibitor Rivaroxaban on Arterial Thrombosis in Wild-Type and Apolipoprotein E-Deficient Mice
27 January 2012
Nana-Maria Wagner, Tobias Dressel, Katrin Schäfer, Stavros Konstantinides
Abstract: Rivaroxaban is a potent and specific direct inhibitor of coagulation factor Xa. Recent studies have highlighted its effectiveness in the prevention of venous thrombosis and embolic stroke du...
Podoplanin expression in advanced atherosclerotic lesions of human aortas
27 January 2012
Kinta Hatakeyama, Mika Kato Kaneko, Yukinari Kato, Tetsunori Ishikawa, Kensaku Nishihira, Yuta Tsujimoto, Yoshisato Shibata, Yukio Ozaki, Yujiro Asada
Abstract: Thrombus formation on disrupted atherosclerotic lesion is a key mechanism of cardiovascular events. Podoplanin (Aggrus), expressed on the surface of several tumor cells, is an endogenous lig...
Bridging with the Low molecular weight heparin certoparin in patients requiring temporary discontinuation of oral anticoagulation – the non-interventional, retrospective REMEMBER study
27 January 2012
Ralf Eisele, Nima Melzer, Cornelia Englert, Peter Bramlage, Michael Spannagl
Abstract: Background: Bridging of a temporal discontinuation of oral anticoagulation with low molecular weight heparins (LMWH) is common practice. Specific data on the LMWH certoparin are however limi...

View More Articles in Press...

On the Cover

New Issue Alert

Free Trial Issue

Journal Access

Full-text articles are available from 1995 to the present. Access to abstracts is complimentary. Access to full text is limited to personal subscribers.

Activate Online Access

CME Resource

Access ThrombosisClinic.com for a continuing medical education resource emphasizing the latest in emerging approaches in the diagnosis, treatment, and prevention of thrombosis.

Publishing Information

Thrombosis Research is published by Elsevier.

Access this journal onSciVerse ScienceDirect

Attention Authors

Thrombosis Research requires that all manuscripts be submitted electronically.
Submit Manuscript

You may also use this system to track your manuscript through the review process.
Track Manuscript

You may also view author guidelines or track your article, post acceptance, by visiting:
Author Gateway

Society Information

More Information

About Thrombosis Research

Thrombosis Research was established in 1972 and is an international journal with a goal of rapid dissemination of new information on thrombosis, hemostasis, and vascular biology to advance science and clinical care. The journal publishes peer-reviewed original research, along with reviews, editorials, and opinions and critics. Both basic and clinical studies are published. Publication of research which will lead to novel approaches in diagnosis, therapy, prognosis and prevention of thrombotic and hemorrhagic diseases is given high priority. Rapid communication and high visibility is facilitated by on-line submission, processing, and dissemination.